compounded semaglutide with niacinamide Tirzepatide clients—this one's for you!

Overview of Available GLP-1 RAs in the UK and Europe A number of GLP-1 RAs have been approved in the UK and Europe for the treatment of T2D (Table 1)

While minoxidil targets blood flow and hair cycle timing, GHK-Cu operates at the genetic level, influencing the expression of thousands of genes involved in tissue repair and regeneration

Two systematic reviews on GLP-1 receptor agonists and body composition published almost simultaneously in 2026

Dong LG, Lu FF, Zu J, Zhang W, Xu CY, Jin GL, Yang XX, Xiao QH, Cui CC, Xu R, Zhou S, Zhu JN, Shen T, Cui GY (2020) MiR-133b inhibits MPP+-induced apoptosis in Parkinsons disease model by inhibiting the ERK1/2 signaling pathway

Common side effects can include pain at the injection site, mild diarrhea, and itching